188 related articles for article (PubMed ID: 36639418)
1. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma.
Pai G; Roohollahi K; Rockx D; de Jong Y; Stoepker C; Pennings C; Rooimans M; Vriend L; Piersma S; Jimenez CR; De Menezes RX; Van Beusechem VW; Brakenhoff RH; Te Riele H; Wolthuis RMF; Dorsman JC
Commun Biol; 2023 Jan; 6(1):37. PubMed ID: 36639418
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource.
Nguyen HT; Tang W; Webster ALH; Whiteaker JR; Chandler CM; Errazquin R; Roohollahi K; Fritzke M; Hoskins EE; Jonlin E; Wakefield L; Sullivan LB; Chen EY; Dorsman J; Brakenhoff R; Paulovich AG; Grompe M; Garcia-Escudero R; Wells SI; Smogorzewska A; Monnat RJ
Int J Cancer; 2023 Jul; 153(1):183-196. PubMed ID: 36912284
[TBL] [Abstract][Full Text] [Related]
3. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
Webster ALH; Sanders MA; Patel K; Dietrich R; Noonan RJ; Lach FP; White RR; Goldfarb A; Hadi K; Edwards MM; Donovan FX; Hoogenboezem RM; Jung M; Sridhar S; Wiley TF; Fedrigo O; Tian H; Rosiene J; Heineman T; Kennedy JA; Bean L; Rosti RO; Tryon R; Gonzalez AM; Rosenberg A; Luo JD; Carroll TS; Shroff S; Beaumont M; Velleuer E; Rastatter JC; Wells SI; Surrallés J; Bagby G; MacMillan ML; Wagner JE; Cancio M; Boulad F; Scognamiglio T; Vaughan R; Beaumont KG; Koren A; Imielinski M; Chandrasekharappa SC; Auerbach AD; Singh B; Kutler DI; Campbell PJ; Smogorzewska A
Nature; 2022 Dec; 612(7940):495-502. PubMed ID: 36450981
[TBL] [Abstract][Full Text] [Related]
4. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
5. The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics.
Martens-de Kemp SR; Brink A; van der Meulen IH; de Menezes RX; Te Beest DE; Leemans CR; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
Mol Cancer Ther; 2017 Mar; 16(3):540-550. PubMed ID: 27980104
[TBL] [Abstract][Full Text] [Related]
6. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
7. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
[TBL] [Abstract][Full Text] [Related]
8. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
[TBL] [Abstract][Full Text] [Related]
11. Mutated
Bertola N; Degan P; Cappelli E; Ravera S
Cells; 2022 Jul; 11(15):. PubMed ID: 35954197
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.
Scheckenbach K; Wagenmann M; Freund M; Schipper J; Hanenberg H
Klin Padiatr; 2012 Apr; 224(3):132-8. PubMed ID: 22504776
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
Montanuy H; Martínez-Barriocanal Á; Antonio Casado J; Rovirosa L; Ramírez MJ; Nieto R; Carrascoso-Rubio C; Riera P; González A; Lerma E; Lasa A; Carreras-Puigvert J; Helleday T; Bueren JA; Arango D; Minguillón J; Surrallés J
Clin Cancer Res; 2020 Jun; 26(12):3044-3057. PubMed ID: 32005748
[TBL] [Abstract][Full Text] [Related]
14. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
[TBL] [Abstract][Full Text] [Related]
16. Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.
Beddok A; Krieger S; Castera L; Stoppa-Lyonnet D; Thariat J
Oral Oncol; 2020 Sep; 108():104816. PubMed ID: 32480311
[TBL] [Abstract][Full Text] [Related]
17. The fanconi anemia pathway limits human papillomavirus replication.
Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
[TBL] [Abstract][Full Text] [Related]
18. Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.
Romick-Rosendale LE; Hoskins EE; Privette Vinnedge LM; Foglesong GD; Brusadelli MG; Potter SS; Komurov K; Brugmann SA; Lambert PF; Kimple RJ; Virts EL; Hanenberg H; Gillison ML; Wells SI
Clin Cancer Res; 2016 Apr; 22(8):2062-73. PubMed ID: 26603260
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.
Lee RH; Kang H; Yom SS; Smogorzewska A; Johnson DE; Grandis JR
Clin Cancer Res; 2021 Oct; 27(19):5168-5187. PubMed ID: 34045293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
